Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1948.66 (Glytoucan)

Id:1e80b040-9870-515d-955e-8256923f8392

Glytoucan:G45688LI

Results found

Linked to

	Label	Description
	1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G05550LT-GLYCOSEQ00119779 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1948.66 has canonical residue n-glycan core b-d-manp c Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G45688LI-GLYCOSEQ00199796 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1948.66 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000013 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G39477LE-GLYCOSEQ00086840 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G38236XZ-GLYCOSEQ00112556 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1948.66 has canonical residue n-glycan a-d-manp 1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G05550LT-GLYCOSEQ00119780 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G93767EH-GLYCOSEQ00066029 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G17497UW-GLYCOSEQ00079418 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G05550LT-GLYCOSEQ00119779 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1948.66 has canonical residue n-glycan core b-d-manp c

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G45688LI-GLYCOSEQ00199796 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1948.66 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000013 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G39477LE-GLYCOSEQ00086840 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G38236XZ-GLYCOSEQ00112556 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1948.66 has canonical residue n-glycan a-d-manp 1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G05550LT-GLYCOSEQ00119780 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G93767EH-GLYCOSEQ00066029 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1948.66 has glycosequence GLYGEN.GLYCOSEQUENCE:G17497UW-GLYCOSEQ00079418 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.